Breast Cancer Predictive Genetic Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (High Penetrant Genes, Intermediate Penetrant Genes, Low Penetrant Genes); Application (Hospitals, Clinics, Other)

Report Code: TIPRE00021639 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Breast cancer is a specific form of the more general breast disease As a result, typical breast cancer signs include the development of red lumps in the breast, and the formation of lumps in the skin. Many of the risk factors for getting breast cancer are being overweight, inactivity, and drinking too much alcohol.

MARKET DYNAMICS

The global increase in the likelihood of breast cancer and government efforts to decrease the overall mortality rate are also driving the predictive genetic testing for breast cancer diagnosis market In contrast, a restrictive government genetic testing environment for early acquisition of small market competitors, large initial capital investments, and the availability of novel diagnostic tests constrain the predictive breast cancer market.

MARKET SCOPE

The "Breast Cancer Predictive Genetic Testing Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Breast Cancer Predictive Genetic Testing Market with detailed market segmentation by type, application. The Breast Cancer Predictive Genetic Testing Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Breast Cancer Predictive Genetic Testing Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Breast Cancer Predictive Genetic Testing Market is segmented on the basis of type, application. Based on type, the market is segmented as High Penetrant Genes, Intermediate Penetrant Genes, Low Penetrant Genes. Based on application, the market is segmented as Hospitals, Clinics, Other.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Breast Cancer Predictive Genetic Testing Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Breast Cancer Predictive Genetic Testing Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Breast Cancer Predictive Genetic Testing Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Breast Cancer Predictive Genetic Testing Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Breast Cancer Predictive Genetic Testing Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Breast Cancer Predictive Genetic Testing Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Breast Cancer Predictive Genetic Testing Market in the global market. Below mentioned is the list of few companies engaged in the Breast Cancer Predictive Genetic Testing Market.

The report also includes the profiles of key players in Breast Cancer Predictive Genetic Testing Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Roche
  •   Thermo Fisher Scientific
  •   PerkinElmer
  •   Quest Diagnostics
  •   Myriad Genetics
  •   Iverson Genetics
  •   Cancer Genetics
  •   OncoCyte Corporation
  •   NeoGenomics
  •   Invitae

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Breast Cancer Predictive Genetic Testing Market - By Type
1.3.2 Breast Cancer Predictive Genetic Testing Market - By Application
1.3.3 Breast Cancer Predictive Genetic Testing Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BREAST CANCER PREDICTIVE GENETIC TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BREAST CANCER PREDICTIVE GENETIC TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BREAST CANCER PREDICTIVE GENETIC TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. BREAST CANCER PREDICTIVE GENETIC TESTING - GLOBAL MARKET OVERVIEW
6.2. BREAST CANCER PREDICTIVE GENETIC TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. BREAST CANCER PREDICTIVE GENETIC TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. HIGH PENETRANT GENES
7.3.1. Overview
7.3.2. High Penetrant Genes Market Forecast and Analysis
7.4. INTERMEDIATE PENETRANT GENES
7.4.1. Overview
7.4.2. Intermediate Penetrant Genes Market Forecast and Analysis
7.5. LOW PENETRANT GENES
7.5.1. Overview
7.5.2. Low Penetrant Genes Market Forecast and Analysis
8. BREAST CANCER PREDICTIVE GENETIC TESTING MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. BREAST CANCER PREDICTIVE GENETIC TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Breast Cancer Predictive Genetic Testing Market Overview
9.1.2 North America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis
9.1.3 North America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Type
9.1.4 North America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Application
9.1.5 North America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Countries
9.1.5.1 United States Breast Cancer Predictive Genetic Testing Market
9.1.5.1.1 United States Breast Cancer Predictive Genetic Testing Market by Type
9.1.5.1.2 United States Breast Cancer Predictive Genetic Testing Market by Application
9.1.5.2 Canada Breast Cancer Predictive Genetic Testing Market
9.1.5.2.1 Canada Breast Cancer Predictive Genetic Testing Market by Type
9.1.5.2.2 Canada Breast Cancer Predictive Genetic Testing Market by Application
9.1.5.3 Mexico Breast Cancer Predictive Genetic Testing Market
9.1.5.3.1 Mexico Breast Cancer Predictive Genetic Testing Market by Type
9.1.5.3.2 Mexico Breast Cancer Predictive Genetic Testing Market by Application
9.2. EUROPE
9.2.1 Europe Breast Cancer Predictive Genetic Testing Market Overview
9.2.2 Europe Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis
9.2.3 Europe Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Type
9.2.4 Europe Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Application
9.2.5 Europe Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Breast Cancer Predictive Genetic Testing Market
9.2.5.1.1 Germany Breast Cancer Predictive Genetic Testing Market by Type
9.2.5.1.2 Germany Breast Cancer Predictive Genetic Testing Market by Application
9.2.5.2 France Breast Cancer Predictive Genetic Testing Market
9.2.5.2.1 France Breast Cancer Predictive Genetic Testing Market by Type
9.2.5.2.2 France Breast Cancer Predictive Genetic Testing Market by Application
9.2.5.3 Italy Breast Cancer Predictive Genetic Testing Market
9.2.5.3.1 Italy Breast Cancer Predictive Genetic Testing Market by Type
9.2.5.3.2 Italy Breast Cancer Predictive Genetic Testing Market by Application
9.2.5.4 Spain Breast Cancer Predictive Genetic Testing Market
9.2.5.4.1 Spain Breast Cancer Predictive Genetic Testing Market by Type
9.2.5.4.2 Spain Breast Cancer Predictive Genetic Testing Market by Application
9.2.5.5 United Kingdom Breast Cancer Predictive Genetic Testing Market
9.2.5.5.1 United Kingdom Breast Cancer Predictive Genetic Testing Market by Type
9.2.5.5.2 United Kingdom Breast Cancer Predictive Genetic Testing Market by Application
9.2.5.6 Rest of Europe Breast Cancer Predictive Genetic Testing Market
9.2.5.6.1 Rest of Europe Breast Cancer Predictive Genetic Testing Market by Type
9.2.5.6.2 Rest of Europe Breast Cancer Predictive Genetic Testing Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Overview
9.3.2 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis
9.3.3 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Breast Cancer Predictive Genetic Testing Market
9.3.5.1.1 Australia Breast Cancer Predictive Genetic Testing Market by Type
9.3.5.1.2 Australia Breast Cancer Predictive Genetic Testing Market by Application
9.3.5.2 China Breast Cancer Predictive Genetic Testing Market
9.3.5.2.1 China Breast Cancer Predictive Genetic Testing Market by Type
9.3.5.2.2 China Breast Cancer Predictive Genetic Testing Market by Application
9.3.5.3 India Breast Cancer Predictive Genetic Testing Market
9.3.5.3.1 India Breast Cancer Predictive Genetic Testing Market by Type
9.3.5.3.2 India Breast Cancer Predictive Genetic Testing Market by Application
9.3.5.4 Japan Breast Cancer Predictive Genetic Testing Market
9.3.5.4.1 Japan Breast Cancer Predictive Genetic Testing Market by Type
9.3.5.4.2 Japan Breast Cancer Predictive Genetic Testing Market by Application
9.3.5.5 South Korea Breast Cancer Predictive Genetic Testing Market
9.3.5.5.1 South Korea Breast Cancer Predictive Genetic Testing Market by Type
9.3.5.5.2 South Korea Breast Cancer Predictive Genetic Testing Market by Application
9.3.5.6 Rest of Asia-Pacific Breast Cancer Predictive Genetic Testing Market
9.3.5.6.1 Rest of Asia-Pacific Breast Cancer Predictive Genetic Testing Market by Type
9.3.5.6.2 Rest of Asia-Pacific Breast Cancer Predictive Genetic Testing Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Breast Cancer Predictive Genetic Testing Market Overview
9.4.2 Middle East and Africa Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis
9.4.3 Middle East and Africa Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Breast Cancer Predictive Genetic Testing Market
9.4.5.1.1 South Africa Breast Cancer Predictive Genetic Testing Market by Type
9.4.5.1.2 South Africa Breast Cancer Predictive Genetic Testing Market by Application
9.4.5.2 Saudi Arabia Breast Cancer Predictive Genetic Testing Market
9.4.5.2.1 Saudi Arabia Breast Cancer Predictive Genetic Testing Market by Type
9.4.5.2.2 Saudi Arabia Breast Cancer Predictive Genetic Testing Market by Application
9.4.5.3 U.A.E Breast Cancer Predictive Genetic Testing Market
9.4.5.3.1 U.A.E Breast Cancer Predictive Genetic Testing Market by Type
9.4.5.3.2 U.A.E Breast Cancer Predictive Genetic Testing Market by Application
9.4.5.4 Rest of Middle East and Africa Breast Cancer Predictive Genetic Testing Market
9.4.5.4.1 Rest of Middle East and Africa Breast Cancer Predictive Genetic Testing Market by Type
9.4.5.4.2 Rest of Middle East and Africa Breast Cancer Predictive Genetic Testing Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Breast Cancer Predictive Genetic Testing Market Overview
9.5.2 South and Central America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis
9.5.3 South and Central America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Type
9.5.4 South and Central America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Application
9.5.5 South and Central America Breast Cancer Predictive Genetic Testing Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Breast Cancer Predictive Genetic Testing Market
9.5.5.1.1 Brazil Breast Cancer Predictive Genetic Testing Market by Type
9.5.5.1.2 Brazil Breast Cancer Predictive Genetic Testing Market by Application
9.5.5.2 Argentina Breast Cancer Predictive Genetic Testing Market
9.5.5.2.1 Argentina Breast Cancer Predictive Genetic Testing Market by Type
9.5.5.2.2 Argentina Breast Cancer Predictive Genetic Testing Market by Application
9.5.5.3 Rest of South and Central America Breast Cancer Predictive Genetic Testing Market
9.5.5.3.1 Rest of South and Central America Breast Cancer Predictive Genetic Testing Market by Type
9.5.5.3.2 Rest of South and Central America Breast Cancer Predictive Genetic Testing Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BREAST CANCER PREDICTIVE GENETIC TESTING MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BREAST CANCER PREDICTIVE GENETIC TESTING MARKET, KEY COMPANY PROFILES
12.1. ROCHE
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. THERMO FISHER SCIENTIFIC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PERKINELMER
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. QUEST DIAGNOSTICS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MYRIAD GENETICS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. IVERSON GENETICS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CANCER GENETICS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ONCOCYTE CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NEOGENOMICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. INVITAE
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Roche
2. Thermo Fisher Scientific
3. PerkinElmer
4. Quest Diagnostics
5. Myriad Genetics
6. Iverson Genetics
7. Cancer Genetics
8. OncoCyte Corporation
9. NeoGenomics
10. Invitae
11. Myriad Genetics, Inc.
12. Complete Genomics Incorporated
13. Ambry Genetics
TIPRE00021639
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking